Entitlement Offer Prospectus
Released
Released
Announcement PDF
Legacy Minerals Holdings Limited
ACN 650 398 897
Prospectus
Entitlement Offer
For a non-renounceable pro rata entitlement offer by the Company of 1 Share for every 7 Shares held by
Eligible Shareholders at an issue price of $0.135 per Share to raise approximately $1,604,806 (before costs),
together with 1 free attaching New Option for every 2 Shares issued (Entitlement Offer).
This Prospectus is also being issued to make the offers set out in section 1.2 of this Prospectus (Additional
Offers).
The Entitlement Offer is fully underwritten by Discovery Capital (Underwriter).
Important: This is an important document that should be read in its entirety. If you are in any doubt or have
any questions about this document, you should promptly consult your stockbroker, accountant or other
professional adviser.
Contents
Important Information
0
Key Numbers and Dates
2
1
Offer Details
5
2
Effect of the Offers
13
3
Risk Factors
18
4
Applications
25
5
Material Contracts
28
6
Additional Information
35
7
Authorisation
47
Definitions
48
Corporate Directory
51
0
Important Information
General
Publicly available information
This Prospectus is issued by Legacy Minerals Holdings
Limited (ACN 650 398 897) (Company).
Information about the Company is publicly available and
can be obtained from ASIC and ASX (including at
www.asx.com.au). The contents of any website, or
ASIC or ASX filing by the Company are not
incorporated into this Prospectus and do not constitute
part of the Offers. This Prospectus is intended to be
read in conjunction with the publicly available
information in relation to the Company which has been
notified to ASX. Investors should therefore have regard
to the other publicly available information in relation to
the Company before making a decision on whether or
not to invest in the Company or its securities.
The Prospectus is dated 3 December 2023, and a copy
of this Prospectus was lodged with ASIC on that date.
Neither ASIC or ASX take responsibility for the contents
of this Prospectus or the merits of the investment to
which this Prospectus relates.
No securities will be issued pursuant to this Prospectus
later than 13 months after the date of this Prospectus.
This Prospectus is a transaction-specific prospectus for
an offer of continuously quoted securities (as defined in
the Corporations Act) and has been prepared in
accordance with section 713 of the Corporations Act. It
does not contain the same level of disclosure as an
initial public offering prospectus. In making
representations in this Prospectus, regard has been
had to the fact that the Company is a disclosing entity
for the purposes of the Corporations Act and certain
matters may reasonably be expected to be known to
investors and professional advisers whom potential
investors may consult.
Persons wishing to apply for Securities pursuant an
Offers must do so using the relevant Application Form
attached to or accompanying this Prospectus. Before
applying for Securities, investors should carefully read
this Prospectus.
Any investment in the Company should be considered
highly speculative. Investors who are in any doubt or
have any questions about this document should
promptly consult their stockbroker, accountant or other
professional adviser before deciding to apply for
securities under the Offers.
No person is authorised to give any information or to
make any representation in relation to the Entitlement
Offer which is not contained in this Prospectus. Any
such information or representations may not be relied
upon as having been authorised by the Company.
Prospectus availability
A copy of this Prospectus can be downloaded from the
Company’s website at https://legacyminerals.com.au.
The Corporations Act prohibits any person passing onto
another person an Application Form unless it is
attached to a hard copy of this Prospectus or it
accompanies the complete and unaltered version of this
Prospectus. Any person may obtain a hard copy of this
Prospectus free of charge by contacting the Company
at +61 2 9959 3520 or the Company Secretary on
info@legacyminerals.com.au.
Not financial product advice
The information in this Prospectus is not financial
product advice and has been prepared without taking
into account your financial and investment objectives,
financial situation or particular needs (including financial
or taxation issues).
No cooling-off rights
Cooling-off rights do not apply to an investment in
securities offered under this Prospectus. This means
that, except where permitted by the Corporations Act,
you cannot withdraw your Application once it has been
accepted.
Foreign restrictions
This Prospectus does not constitute an offer or
invitation in any place in which, or to any person to
whom, it would not be lawful to make such an offer or to
extend such an invitation.
The Offers are not being extended, and Securities will
not be issued, to Shareholders with a registered
address which is outside Australia and New Zealand. It
is not practicable for the Company to comply with the
securities laws of overseas jurisdictions (other than
those mentioned above) having regard to the number of
overseas Shareholders, the number and value of
Securities these Shareholders would be offered and the
cost of complying with regulatory requirements in each
relevant jurisdiction.
No action has been taken to permit the offer of
Securities to existing Shareholders in any jurisdiction
other than Australia and New Zealand.
Please refer to sections 1.5 for further information in
relation to certain foreign jurisdictions.
Target Market Determination
In accordance with the design and distribution
obligations under the Corporations Act, the Company
has determined the target market for the offer of New
Options issued under this Prospectus. The Company
0
and the Lead Manager will only distribute this
Prospectus to those investors who fall within the target
market determination (TMD) as set out on the
Company’s website (https://legacyminerals.com.au). By
making an application under the Offers, you warrant
that you have read and understood the TMD and that
you fall within the target market set out in the TMD.
Risk factors
Before deciding to invest in the Company, investors
should read the entire Prospectus and in particular, in
considering the prospects of the Company, investors
should consider the risk factors that could affect the
financial performance and assets of the Company.
Investors should carefully consider these factors in light
of their personal circumstances (including financial and
tax issues). See section 3 for further information.
Forward-looking statements
Some of the statements appearing in this Prospectus
are in the nature of forward looking statements,
including statements of intention, opinion and belief and
predictions as to possible future events. Such
statements are not statements of fact and are subject to
inherent risks and uncertainties (both known and
unknown) which may or may not be within the control of
the Company. You can identify such statements by
words such as ‘may’, ‘could’, ‘believes’, ‘estimates’,
‘targets’, ‘expects’, or ‘intends’ and other similar words
that involve risks and are predictions or indicative of
future events.
Although the Directors believe these forward-looking
statements (including the assumptions on which they
are based) are reasonable as at the Prospectus Date,
no assurance can be given that such expectations or
assumptions will prove to be correct. Actual outcomes,
events and results may differ, including due to risks set
out in section 6 of this Prospectus.
The Company and its Directors, officers, employees
and advisors cannot and do not give any assurance that
the results, performance or achievements expressed or
implied by the forward-looking statements contained in
this Prospectus will actually occur and investors are
cautioned not to place undue reliance on these forwardupdate or revise forward-looking statements, or to
publish prospective financial information in the future,
regardless of whether new information, future events or
any other factors affect the information contained in this
Prospectus, except where required by law.
Financial amounts
All references in this Prospectus to “$”, “A$”, “AUD”,
“dollars” or “cents” are references to Australian currency
unless otherwise disclosed.
Any discrepancies between the totals and sums of
components in tables contained in this Prospectus are
due to rounding.
Definitions and time
A number of terms and abbreviations used in this
Prospectus have defined meanings which are set out in
the Definitions section of this Prospectus.
All references to time relate to the time in Sydney, New
South Wales unless otherwise stated or implied.
Governing law
This Prospectus and the contracts that arise from the
acceptance of applications under this Prospectus are
governed by the law applicable in New South Wales
and each applicant submits to the exclusive jurisdiction
of the courts of New South Wales.
1
Key Numbers and Dates
Key Offer Details
Ratio
One (1) Share for every seven (7) Shares
held by Eligible Shareholders on the
Record Date
Issue price of Shares under the Entitlement Offer
$0.135
Shares offered under the Entitlement Offer
11,887,453
New Options offered under the Entitlement Offer
5,943,727
Issue price of New Options under the Entitlement Offer
Nil
Funds to be raised (before costs)
$1,604,806
New Options to be issued under the Underwriter Offer1
3,962,484
New Options to be issued under the Placement Offer2
5,177,688
New Options to be issued under the Lead Manager Offer3
4,000,000
Notes:
1
See section 1.2.2 for further details.
2
See section 1.2.3 for further details.
3
See section 1.2.4 for further details. New Options offered under the Lead Manager Offer have an issue price of $0.000001
each.
Key Events1
Announcement of the Offers and release of Appendix 3B
Prospectus lodged with ASIC
Shares quoted on an “Ex” basis
Record Date
Shares issued pursuant to the Placement
Date
Wednesday, 29 November 2023
Sunday, 3 December 2023
Wednesday, 6 December 2023
5:00pm (Sydney time) on Thursday, 7
December 2023
Friday, 8 December 2023
Dispatch of Prospectus (together with Application Form) to
Eligible Shareholders
Monday, 11 December 2023
Opening Date
Monday, 11 December 2023
Last date to extend Closing Date
Closing Date
Securities quoted on a deferred settlement basis
Before 12:00pm (Sydney time) on
Wednesday, 27 December 2023
5:00pm (Sydney time) on Tuesday, 2
January 2024
Wednesday, 3 January 2024
2
Shortfall announced to ASX
Issue of Shares and New Options
Despatch of holding statements
Friday, 5 January 2024
Before 12:00pm (Sydney time) on Friday, 5
January 2024
Lodgement of Appendix 2A
Quotation of Securities issued under the Entitlement Offer
Monday, 8 January 2024
Underwriter and sub-underwriter(s) subscribes for
Shortfall Securities
Monday, 15 January 2024
Issue date and lodgement of Appendix 2A for Shortfall
Securities
Quotation of Shortfall Securities
Wednesday, 17 January 2024
Friday, 19 January 2024
Anticipated date of General Meeting and issue of New
Options pursuant to Underwriter Offer, Lead Manager
Offer and Placement Offer
Monday, 22 January 2024
Anticipated date of lodgement of Appendix 2A for New
Options pursuant to Underwriter Offer, Lead Manager
Offer and Placement Offer
Monday, 22 January 2024
Anticipated date of quotation of New Options pursuant to
Underwriter Offer, Lead Manager Offer and Placement
Offer
Tuesday, 23 January 2024
Notes:
1
The above timetable is indicative only. The Company reserves the right, subject to the Corporations Act, the Listing Rules and
other applicable laws, to vary the dates, including by extending the Closing Date of the Offers or accepting late acceptances, either
generally or in particular cases, without notice.
3
Chair's Letter
3 December 2023
Dear Shareholders
On behalf of the Board, I am pleased to present you with the Company's non-renounceable pro-rata
entitlement offer. Each Eligible Shareholder is being offered the right to acquire additional Shares in the
Company at an issue price of $0.135 per Share, to raise approximately $1,604,806 (before costs). This has
been determined on the basis of 1 new Share for every 7 Shares registered in your name as at the Record
Date. You will also receive 1 free attaching New Option for every 2 Shares issued under the Entitlement
Offer, with the New Options proposed to be quoted.
The Company’s strategy is to define, drill and develop a pipeline of prospective targets for gold and copper
mineralisation in world class jurisdictions like New South Wales. Underlying this strategy is a detailed
exploration methodology that applies modern analytical tools to historic data, supported by meticulous
analysis of surface features, to construct geological models to assist in the identification of high value and
high conviction drill targets.
This exploration methodology has been successfully implemented across the portfolio, notably at the
Bauloora Project where our team, led by Technical Director, Thomas Wall, is managing the exploration under
the farm-in and joint venture agreement with Newmont Exploration. The team refined the geological model
based upon the exploration results that were used for targeting the Breccia Sinter Prospect. The subsequent
diamond drilling identified mineralogy and textures consistent with the top of the boiling zone which is
commonly well mineralised in these types of systems and gives confidence to the prospectivity at depth.
We are now applying this same methodology at the Sugarbag Hill Prospect, part of the Black Range Project.
At Sugar Bag Hill, we have remodelled the historical induced polarisation data and conducted soil analysis
and have identified features consistent with low-sulphidation, epithermal gold-silver style mineralisation.
These features were unrecognised by previous explorers and remain untested by drilling.
The funds raised from the Entitlement Offer are to be used to advance exploration and drilling programs on
the Company’s recently granted Black Range Project in NSW, as well as generative works and drilling on its
other 100% owned, and general working capital.
This Prospectus contains information about the Offers and the key risks associated with investing in the
Company (see section 3), and it is intended to be read in conjunction with the publicly available information
in relation to the Company which has been notified to ASX. An investment in the Company should be
considered highly speculative. If you do not understand this Prospectus, then you should contact your
professional adviser.
The Board and Management of the Company appreciates the ongoing support of our shareholders and
encourage all to review the Offer documentation and participate in the Entitlement Offer, allowing us to
unlock the value in the Company and deliver value to our owners.
Yours sincerely
David Carland
Non-Executive Chairman
Legacy Minerals Holdings Limited
4
1
Offer Details
1.1
Entitlement Offer
The Company is making a non-renounceable pro rata entitlement offer to Eligible Shareholders on
the basis of 1 Share for every 7 Shares held on the Record Date at an issue price of $0.135 per
Share to raise up to $1,604,806 (before costs), together with 1 free attaching New Option for every 2
Shares subscribed for and issued (exercisable at $0.205 each on or before 22 January 2026)
(Entitlement Offer). Fractional entitlements will be rounded down to the nearest whole number.
Discovery Capital Partners Pty Ltd (ACN 615 635 982) (Discovery Capital) has agreed to fully
underwrite the Entitlement Offer. Please refer to section 5.1 for further details.
The issue price represents the following discounts to the Company’s closing price of Shares on 24
November 2023 of $0.165, prior to the Company entering into trading halt pending the
announcement of the Entitlement Offer on 27 November 2023.
Previous Trading
Offer Discount Price
24 November 2023
$0.1650
18.2%
5-day VWAP
$0.1590
15.1%
10-day VWAP
$0.1576
14.3%
15-day VWAP
$0.1577
14.4%
As at the Prospectus Date, the Company has on issue 83,212,169 Shares and 5,251,833 unquoted
Options with various exercise prices and expiry dates. Please refer to section 2.2 for more details on
the Company’s current capital structure.
On the assumption that no Options are exercised before the Record Date, the Company proposes to
offer approximately 11,877,453 Shares and 5,943,727 New Options under the Entitlement Offer. The
Company also proposes to issue 13,140,172 New Options pursuant to the Additional Offers (please
refer to section 1.2 below for further details).
Shares issued under the Entitlement Offer will be issued as fully paid ordinary shares and will rank
equally in all respects with existing Shares on issue. Please refer to section 6.7 for a summary of the
rights and liabilities attaching to Shares. New Options to be issued under the Entitlement Offer will be
issued on the terms and conditions contained in section 6.8.
1.2
Additional Offers
Pursuant to this Prospectus, the Company is also making the Additional Offers. The Additional Offers
are being made under this Prospectus to:
•
ensure that the Securities offered pursuant to the Additional Offers are made in accordance
with the disclosure requirements of Part 6D.2 of the Corporations Act; and
•
remove the need for an additional disclosure document to be issued upon the sale of any
Shares and New Options (including any Shares issued on exercise of any New Options) that
are issued pursuant to the Additional Offers.
5
1.2.1
Shortfall Offer
Any Shares and New Options not taken up pursuant to the Entitlement Offer will become Shortfall
Securities (Shortfall Offer). The Shortfall Offer is a separate offer of the Shortfall Securities made
pursuant to this Prospectus and will remain open for up to 3 months following the Closing Date.
Shortfall Securities issued under the Shortfall Offer shall be granted on the same terms and
conditions as the Shares and New Options being offered under the Entitlement Offer. Shortfall
Securities will only be issued if the Entitlement Offer is undersubscribed and will only be issued to
the extent necessary to make up any shortfall in subscriptions. It is possible that there will be few or
no Shortfall Securities available under the Shortfall Offer, depending on the level of take up of
Entitlements by Eligible Shareholders under the Entitlement Offer.
Eligible Shareholders who wish to subscribe for Shortfall Securities pursuant to the Shortfall Offer
may apply by completing the relevant section on the Application Form or by making payment for
such Shortfall Securities via Electronic Funds Transfer or using BPAY® (refer to section 4.6).
The Board has the discretion to elect to cap the number of Shortfall Securities applied for by Eligible
Shareholders, having regard to:
•
the number of Securities that an Eligible Shareholders is entitled to subscribe for pursuant to
its Entitlement relative to the number of Shortfall Securities that it has applied for;
•
the total number of Shortfall Securities available for subscription; and
•
the number of Shares held by an Eligible Shareholder after the completion of the Offers.
Allocation of the Shortfall Shares will be at the discretion of the Board in conjunction with the
Underwriter and will otherwise be subject to the terms of the Underwriting Agreement, the key terms
of which are set out in section 5.1. If the Entitlement Offer is oversubscribed (by take up of
Entitlements and applications for Shortfall Securities by Eligible Shareholders), scale back will be
applied to applications under the Shortfall Offer on a pro-rata basis to the respective shareholdings
of Eligible Shareholders. There is no guarantee that Eligible Shareholders will receive Securities
applied for under the Shortfall Offer.
There is no guarantee of any allocation of Shortfall Securities, or that applications for Shortfall
Securities will be satisfied in full. Excess Application Monies for the Shortfall Offer will be refunded
without interest. It is a term of the Shortfall Offer that, should the Company scale back applications
for Shortfall Securities, the Applicant will be bound to accept such lesser number allocated to them.
Any Shares and New Options not applied for under the Entitlement Offer or the Shortfall Offer may
be placed at the Directors’ discretion to sophisticated and professional investors as defined in
sections 708(8), 708(10) and 708(11) of the Corporations Act, subject to the Listing Rules and any
restrictions under applicable law, within 3 months of the close of the Entitlement Offer.
1.2.2
Underwriter Offer
In accordance with the Underwriting Agreement, the Company has agreed to issue New Options to
the Underwriter (or its nominee) for the provision of its services as Underwriter to the Entitlement
Offer (Underwriter Offer). See section 5.1 for a summary of the material terms of the Underwriting
Agreement.
The Offer of 3,962,484 New Options to the Underwriter (or its nominees) is being made pursuant to
this Prospectus.
The issue of the New Options pursuant to the Underwriter Offer is subject to the Company obtaining
the approval of its shareholders at a general meeting to be convened on or around Monday, 22
January 2024.
The Underwriter Offer cannot be accepted by any person or entity other than the Underwriter (or its
nominee). The Underwriter Offer is being made under this Prospectus to remove the need for an
6
additional disclosure document to be issued upon the sale or transfer of any Shares issued upon
exercise of any New Options issued under the Underwriter Offer into Shares.
An Underwriter Offer Application Form will be issued to the Underwriter together with a copy of this
Prospectus.
A summary of the rights and liabilities attaching to the New Options is in section 6.8. Shares issued
upon exercise of the New Options will be fully paid and will rank equally with the Company’s existing
Shares on issue at the date of this Prospectus.
Subject to the requirements of the Listing Rules, the Company intends to apply for quotation of the
New Options issued under the Underwriter Offer.
1.2.3
Placement Offer
As announced on 29 November 2023, the Company received binding commitments from
sophisticated and professional investors for the issue of 10,355,375 Shares at an issue price of
$0.135 per Share to raise approximately $1,397,976 (before costs) (Placement). The Company
proposes to issue the Shares pursuant to the Placement on or about Friday, 8 December 2023 out of
the Company’s available placement capacity under Listing Rules 7.1 and 7.1A. As part of the
Placement, the Company will also issue 5,177,688 free attaching quoted options exercisable at
$0.205 and expiring on 22 January 2026 to Placement Participants on a 1 for 2 basis (New
Options).
The Offer of 5,177,688 New Options to the Placement Participants is being made pursuant to this
Prospectus.
No funds will be raised from the Placement Offer. It is noted that the Company raised approximately
$1,397,976 (before costs) through the issue of Shares pursuant to the Placement.
The issue of the New Options is subject to the Company obtaining the approval of its shareholders at
a general meeting to be convened on or around Monday, 22 January 2024.
Only the Placement Participants may accept the Placement Offer. The Placement Offer is being
made under this Prospectus to remove the need for an additional disclosure document to be issued
upon the sale or transfer of any Shares issued upon exercise of any New Options issued under the
Placement Offer into Shares.
A Placement Offer Application Form will be issued to the participants in the Placement together with
a copy of this Prospectus.
A summary of the rights and liabilities attaching to the New Options is in section 6.8. Shares issued
upon exercise of the New Options will be fully paid and will rank equally with the Company’s existing
Shares on issue at the date of this Prospectus.
Subject to the requirements of the Listing Rules, the Company intends to apply for quotation of the
New Options issued under the Placement Offer.
1.2.4
Lead Manager Offer
In accordance with the Lead Manager Mandate, the Company has agreed to issue New Options to
the Lead Manager (or its nominee) for the provision of its services as Lead Manager to the
Placement (Lead Manager Offer). See section 5.2 for a summary of the material terms of the Lead
Manager Mandate.
The Offer of 4,000,000 New Options to the Lead Manager is being made pursuant to this
Prospectus.
$4 will be raised under the Lead Manager Offer as the New Options are being issued for nominal
consideration, being $0.000001 per New Option, as partial consideration for lead management
services provided to the Company by the Lead Manager pursuant to the Placement.
7
The issue of the New Options is subject to the Company obtaining the approval of its shareholders at
a general meeting to be convened on or around Monday, 22 January 2024.
The Lead Manager Offer cannot be accepted by any person or entity other than the Lead Manager
(or its nominee). The Lead Manager Offer is being made under this Prospectus to remove the need
for an additional disclosure document to be issued upon the sale or transfer of any Shares issued
upon exercise of any New Options issued under the Lead Manager Offer into Shares.
A Lead Manager Offer Application Form will be issued to the Lead Manager together with a copy of
this Prospectus.
A summary of the rights and liabilities attaching to the New Options is in section 6.8. Shares issued
upon exercise of the New Options will be fully paid and will rank equally with the Company’s existing
Shares on issue at the date of this Prospectus.
Subject to the requirements of the Listing Rules, the Company intends to apply for quotation of the
New Options issued under the Lead Manager Offer.
1.3
Proposed use of funds
The purpose of the Entitlement Offer is to raise approximately $1,604,806 (before costs). Together
with funds raised from the Placement of approximately $1,397,976 (before costs), the Company
intends to use this amount as follows:
Item
Amount
Geochemistry, drilling, and assays at Black Range1
$1,037,510
Geophysics, geochemistry, and drill target definition at Cowra, Drake,
Rockley and Cobar2
$1,157,496
Costs of the Offers and Placement (excluding GST)3
$245,976
Working capital4
$561,800
Total
$3,002,782
Notes:
1
Exploration activities will include ground based geochemical sampling (rock chip and soil sampling) as well as ground
based geophysical surveying including included polarisation. Drilling will include a combination of reserve circulation
and diamond coring.
2
Exploration activities will include ground based geochemical sampling (rock chip and soil sampling) as well as ground
based geophysical surveying for the purpose of defining drill targets for testing.
3
See section 6.14 for further details. Includes costs for underwriting the Entitlement Offer, estimated costs of the
Entitlement Offer, the estimated costs of the Placement and the estimated fees associated with the quotation of the
Underwriter Options, Lead Manager Options and Placement Options.
4
Working capital may include wages, payments to contractors, rent and outgoings, insurance, accounting, audit, legal
and listing fees, payments to creditors, interest payments, other items of a general administrative nature and cash
reserves, as determined by the Board at the relevant time.
The above table is a statement of the Board’s current intention at the date of this Prospectus.
However, investors should note that, as with any budget, the allocation of funds set out in the above
table may change depending on a number of factors, including the outcome of exploration,
operational and development activities, regulatory developments, market and general economic
conditions and environmental factors. The Company reserves the right to alter the way the funds are
applied.
8
1.4
Who is eligible to participate in the Entitlement Offer?
1.4.1
Eligible Shareholders
For the purposes of the Entitlement Offer, Eligible Shareholders are those persons who:
1.4.2
•
are registered as a holder of Shares at 5:00pm (AEDT) on the Record Date; and
•
have a registered address in Australia and New Zealand.
Ineligible Shareholders
Shareholders who are not Eligible Shareholders are Ineligible Shareholders.
This Prospectus, and any accompanying Application Form, do not, and are not intended to,
constitute an offer of Shares or New Options in any place or jurisdiction in which, or to any person to
whom, it would not be lawful to make such an offer or to issue this Prospectus or the Shares under
the Entitlement Offer.
The distribution of this Prospectus in jurisdictions outside Australia may be restricted by law and
persons who come into possession of this Prospectus should seek advice on and observe any such
restrictions. Any failure to comply with such restrictions may constitute a violation of applicable
securities laws.
In accordance with Listing Rule 7.7.1, the Company has determined that it would be unreasonable to
extend the Entitlement Offer to Ineligible Shareholders, having regard to:
•
the small number of Ineligible Shareholders;
•
the small number and value of the securities which would be offered to Ineligible
Shareholders if they were Eligible Shareholders; and
•
the cost of complying with the legal and regulatory requirements in the respective overseas
jurisdictions.
Accordingly, the Entitlement Offer is not being extended to any Shareholders outside Australia and
New Zealand. The Company will notify all Ineligible Shareholders of the Entitlement Offer and advise
that the Company is not extending the Entitlement Offer to those Shareholders.
1.5
International offer restrictions
This
Share your feedback
Discover